Related Experiment Video
Updated: Jan 19, 2026

Development of a Virtual Reality Assessment of Everyday Living Skills
Published on: April 23, 2014
Long-Acting Injectable versus Oral Antipsychotics for Restoration of Competency to Stand Trial
Elias Ghossoub1, Susan Minchin2, Davinder Hayreh2
1Dr. Ghossoub is Assistant Professor of Clinical Psychiatry, American University of Beirut, and Dr. Newman is Professor, Forensic Psychiatry Division, Department of Psychiatry and Behavioral Neuroscience, Saint Louis University, Saint Louis, Missouri. Drs. Minchin and Hayreh are Psychiatrists, Metropolitan Saint Louis Psychiatric Center, Saint Louis, Missouri. elias.ghossoub@gmail.com.
Antipsychotic treatment is key for restoring trial competency in individuals with psychotic disorders. This study found long-acting injectable antipsychotics were not significantly linked to improved competency restoration rates compared to other forms.
Area of Science:
- Forensic Psychiatry
- Psychopharmacology
- Clinical Psychology
Background:
- Antipsychotic medication is crucial for competency restoration in defendants with psychotic disorders.
- Most defendants found incompetent to stand trial have psychotic illnesses.
Purpose of the Study:
- To investigate the association between antipsychotic type and trial competency restoration in defendants with psychotic disorders.
- To determine if long-acting injectable antipsychotics improve competency restoration rates.
Main Methods:
- Retrospective analysis of defendants diagnosed with psychotic disorders and deemed incompetent to stand trial.
- Utilized regression models to calculate the odds ratio of competency restoration.
- Adjusted for relevant confounding variables.
Main Results:
- Long-acting injectable antipsychotics showed no significant association with increased odds of trial competency restoration.
- The study did not find a statistically significant benefit of long-acting injectables over other antipsychotic formulations for competency restoration.
Conclusions:
- Current findings suggest long-acting injectable antipsychotics may not offer a significant advantage in restoring trial competency for this population.
- Larger, longitudinal studies are needed to compare the efficacy and tolerability of long-acting injectable versus oral antipsychotics in competency restoration.
- Further research is essential for developing evidence-based treatment guidelines for trial competency restoration.
More Related Videos
Related Concept Videos
Psychosis: Goals of Pharmacotherapy
Psychosis and Antipsychotic Drugs: Overview
Drug Therapy
Antianxiety Medications
Antipsychotic Drugs: Typical and Atypical Agents
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Nondepolarizing (Competitive) Neuromuscular Blockers: Pharmacokinetics
Instead, they are transported by the blood to different tissues. Muscles with a greater blood supply (arteries) and blood flow receive more...

